Oragenics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 84.83 K | $17.82 K | 120.42% | 0.47% |
GSB WEALTH MANAGEMENT, LLC | 04/18/2025 | 30.93 K | $6.50 K | 53.09% | 0.17% |
TWO SIGMA SECURITIES, LLC | 05/15/2025 | 25.11 K | $5.27 K | 47.98% | 0.14% |
XTX TOPCO LTD | 05/08/2025 | 24.85 K | $5.22 K | -36.17% | 0.14% |
BLACKROCK, INC. | 05/02/2025 | 21.06 K | $4.42 K | 0.00% | 0.12% |
LIONSBRIDGE WEALTH MANAGEMENT LLC | 05/14/2025 | 20.00 K | $4.20 K | 0.00% | 0.11% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 18.23 K | $3.83 K | -7.32% | 0.10% |
MUTUAL ADVISORS, LLC | 04/28/2025 | 16.00 K | $3.15 K | 100.00% | 0.09% |
HBK SORCE ADVISORY LLC | 04/23/2025 | 13.63 K | $2.86 K | 0.00% | 0.07% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 7.48 K | $1.57 K | -1.14% | 0.04% |
UBS GROUP AG | 05/13/2025 | 5.99 K | $1.26 K | 18.47% | 0.03% |
MORGAN STANLEY | 05/15/2025 | 4.59 K | $965 | 5.93% | 0.03% |
HEXAGON CAPITAL PARTNERS LLC | 04/29/2025 | 275 | $58 | 100.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 208 | $44 | 2.46% | 0.00% |
JPMORGAN CHASE & CO | 05/12/2025 | 186 | $39 | -40.38% | 0.00% |
ACTIVEST WEALTH MANAGEMENT | 05/15/2025 | 34 | $7 | 0.00% | 0.00% |
05/02/2025 | 29 | $6 | 0.00% | 0.00% | |
EVERMAY WEALTH MANAGEMENT LLC | 05/07/2025 | 2 | $1 | 0.00% | 0.00% |
HRT FINANCIAL LP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
WARBERG ASSET MANAGEMENT LLC | 05/09/2025 | 0 | $0 | -100.00% | 0.00% |
WOLFF WIESE MAGANA LLC | 04/22/2025 | 0 | $0 | -100.00% | 0.00% |
Oragenics, Inc. institutional Ownership - FAQ's
During the previous two years, 21 institutional investors and hedge funds held shares of Oragenics, Inc.. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 84,826
GSB Wealth Management, LLC: 30,927
TWO SIGMA SECURITIES, LLC: 25,107
XTX Topco Ltd: 24,845
BlackRock, Inc.: 21,059
Lionsbridge Wealth Management LLC: 20,000
1.50% of Oragenics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 294.44 K shares in the last 24 months. This purchase volume represents approximately $451.97 K in transactions.